Company Filing History:
1 out of 8 
1 out of 49 
Years Active: 2020
Title: The Innovations of Harald Kratz
Introduction
Harald Kratz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, his work focuses on improving the health outcomes of patients with renal function impairments.
Latest Patents
Kratz's latest patents include a drug based on maghemite for the simultaneous reduction of gastrointestinal sodium resorption and phosphate resorption. This invention features a substance based on nanocrystalline maghemite, which has a crystal size ranging from 0.5 to 4 nm. The formulation aims to reduce the transport of sodium and phosphate in the gastrointestinal wall, thereby improving electrolyte and mineral balances in patients with impaired renal function when used orally in combination with suitable pharmaceutical adjuvants.
Another significant patent is a nanoparticulate phosphate adsorbent based on maghemite or maghemite/magnetite. This invention comprises an iron oxide core with a crystal structure of inverse spinel iron oxide, coated with monomeric carbohydrates or pharmaceutical excipients. The phosphate adsorbent is designed in the form of nanoparticles with a particle size of less than 20 nm. This invention also includes methods for production and medical uses, particularly for the prevention and treatment of hyperphosphatemia.
Career Highlights
Throughout his career, Kratz has worked with prestigious institutions such as Charité - Universitätsmedizin Berlin. His research and innovations have contributed to advancements in medical treatments and pharmaceutical applications.
Collaborations
Some of his notable coworkers include Susanne Wagner and Matthias Taupitz. Their collaborative efforts have further enhanced the impact of Kratz's inventions in the medical field.
Conclusion
Harald Kratz's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care through advanced drug formulations. His patents reflect a deep understanding of the complexities of renal function and the need for effective treatments.